Patents by Inventor Daphne Chan

Daphne Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
    Publication number: 20250296998
    Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequent subcutaneous doses in order for the patient to respond to the antibody and meet one or more of the clinical endpoints.
    Type: Application
    Filed: March 20, 2025
    Publication date: September 25, 2025
    Inventors: Omoniyi Adedokun, Daphne Chan, Yang Chen, Philippe Szapary, Jewel Johanns, Zijiang Yang, Natalie A Terry
  • Methods of treating Crohn's disease with anti-IL23 specific antibody
    Patent number: 12138295
    Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequence subcutaneous doses.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: November 12, 2024
    Inventors: Omoniyi Adedokun, Daphne Chan, Yang Chen, Philippe Szapary
  • Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
    Publication number: 20240368265
    Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequent subcutaneous doses in order for the patient to respond to the antibody and meet one or more of the clinical endpoints.
    Type: Application
    Filed: July 8, 2024
    Publication date: November 7, 2024
    Inventors: Omoniyi Adedokun, Daphne Chan, Yang Chen, Philippe Szapary
  • Method of Treating Psoriasis with IL-23 Specific Antibody
    Publication number: 20230312703
    Abstract: A method of treating mild to moderate psoriasis in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial dose and subsequent doses in order for the patient to respond to the antibody and meet one or more of the clinical endpoints.
    Type: Application
    Filed: March 30, 2023
    Publication date: October 5, 2023
    Inventors: Daphne Chan, Olivia Choi, Long-Long Gao, Jenny Jeyarajah, Shu Li, Katelyn Rowland, Vikash Sinha, Yanli Wang
  • Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
    Publication number: 20230151087
    Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequent subcutaneous doses in order for the patient to respond to the antibody and meet one or more of the clinical endpoints.
    Type: Application
    Filed: November 14, 2022
    Publication date: May 18, 2023
    Inventors: Omoniyi Adedokun, Daphne Chan, Yang Chen, Philippe Szapary
  • Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
    Publication number: 20210347880
    Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequent subcutaneous doses in order for the patient to respond to the antibody and meet one or more of the clinical endpoints.
    Type: Application
    Filed: May 5, 2021
    Publication date: November 11, 2021
    Inventors: Omoniyi Adedokun, Daphne Chan, Yang Chen, Philippe Szapary
  • Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
    Publication number: 20210308220
    Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequence subcutaneous doses.
    Type: Application
    Filed: March 25, 2021
    Publication date: October 7, 2021
    Inventors: Omoniyi Adedokun, Daphne Chan, Yang Chen, Philippe Szapary
  • Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
    Publication number: 20190269757
    Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequence subcutaneous doses.
    Type: Application
    Filed: March 4, 2019
    Publication date: September 5, 2019
    Inventors: Omoniyi Adedokun, Daphne Chan, Yang Chen, Philippe Szapary